Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab

David F. McDermott, Michael B. Atkins, Julie R. Brahmer et al.|Journal of Clinical Oncology|2015

Cited by 443